Cargando…
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
BACKGROUND: COVID-19 is a highly infectious respiratory disease. No therapeutics have yet been proven effective for treating severe COVID-19. OBJECTIVES: To determine whether human umbilical cord mesenchymal stem cell infusion may be effective and safe for the treatment of severe COVID-19. METHODS:...
Autores principales: | Shu, Lei, Niu, Changming, Li, Ruyou, Huang, Tingrong, Wang, Yan, Huang, Mao, Ji, Ningfei, Zheng, You, Chen, Xiaolin, Shi, Lei, Wu, Mingjing, Deng, Kaili, Wei, Jing, Wang, Xueli, Cao, Yang, Yan, Jiaxin, Feng, Ganzhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432540/ https://www.ncbi.nlm.nih.gov/pubmed/32811531 http://dx.doi.org/10.1186/s13287-020-01875-5 |
Ejemplares similares
-
One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment
por: Shi, Lei, et al.
Publicado: (2022) -
Analysis of the correlation between BMI and respiratory tract microbiota in acute exacerbation of COPD
por: Cao, Yang, et al.
Publicado: (2023) -
Treatment of refractory secondary hemophagocytic lymphohistiocytosis with umbilical cord mesenchymal stem cells
por: Yang, Xiaoyang, et al.
Publicado: (2019) -
Nucleus-Targeting
Manganese Dioxide Nanoparticles
Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane
for Cancer Cell Therapy
por: Xie, Lixu, et al.
Publicado: (2023) -
Umbilical cord mesenchymal stem cells promote the repair of trochlear groove reconstruction in dogs
por: He, Shi, et al.
Publicado: (2022)